Overview

Montelukast in Perennial Allergic Rhinitis - 2001-2002 Study (0476-246)

Status:
Completed
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
This study will assess the ability of montelukast to improve the signs and symptoms of perennial allergic rhinitis compared to placebo. Cetirizine is included in the study as an active control.
Phase:
Phase 3
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Cetirizine
Montelukast